FDA accepts Teva, Alvotech BLAs for Simponi biosimilars
Source: SeekingAlpha
2025-01-27 10:59:54 ET
More on Teva Pharmaceutical
- Top 4 Immunology Stocks Poised For Growth In 2025
- Teva Pharmaceutical Industries Limited (TEVA) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)
- Duvakitug And Teva's Growth: A Game Changer In Pharma
- Teva multiple sclerosis drug Copaxone gets boxed warning on anaphylaxis risk
- Teva sues CMS over Medicare drug price negotiations
Read the full article on Seeking Alpha
For further details see:
FDA accepts Teva, Alvotech BLAs for Simponi biosimilars
Alvotech
NASDAQ: ALVO
ALVO Trading
-6.23% G/L:
$3.01 Last:
679,105 Volume:
$3.23 Open:
ALVO Latest News
May 11, 2026 04:30:00 am
Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility
ALVO Stock Data
$1,569,389,520
107,654,085
N/A
30
N/A
Pharmaceuticals
Healthcare
LU
Luxembourg
